Wine Compounds as a Source for HTS Screening Collections. A Feasibility Study
暂无分享,去创建一个
[1] Nicolas Foloppe,et al. Drug-like Annotation and Duplicate Analysis of a 23-Supplier Chemical Database Totalling 2.7 Million Compounds , 2004, J. Chem. Inf. Model..
[2] D. Pereira,et al. Origin and evolution of high throughput screening , 2007, British journal of pharmacology.
[3] S. Yalkowsky,et al. Estimation of the aqueous solubility I: application to organic nonelectrolytes. , 2001, Journal of pharmaceutical sciences.
[4] B. Jayaprakasam,et al. Impact of alkyl esters of caffeic and ferulic acids on tumor cell proliferation, cyclooxygenase enzyme, and lipid peroxidation. , 2006, Journal of agricultural and food chemistry.
[5] Stephen R. Johnson,et al. Molecular properties that influence the oral bioavailability of drug candidates. , 2002, Journal of medicinal chemistry.
[6] P. Coumel,et al. [Long-term clinical results of the implantable automatic defibrillator]. , 1987, Archives des maladies du coeur et des vaisseaux.
[7] De-Xing Hou,et al. Potential mechanisms of cancer chemoprevention by anthocyanins. , 2003, Current molecular medicine.
[8] J. Hollis,et al. Analysis of betaine and choline contents of aleurone, bran, and flour fractions of wheat (Triticum aestivum L.) Using (1)H nuclear magnetic resonance (NMR) spectroscopy. , 2009, Journal of agricultural and food chemistry.
[9] Matthew A Cooper,et al. Drug-likeness and increased hydrophobicity of commercially available compound libraries for drug screening. , 2012, Current topics in medicinal chemistry.
[10] J. Hughes,et al. Physiochemical drug properties associated with in vivo toxicological outcomes. , 2008, Bioorganic & medicinal chemistry letters.
[11] Jóhannes Reynisson,et al. Characteristics of known drug space. Natural products, their derivatives and synthetic drugs. , 2010, European journal of medicinal chemistry.
[12] R. Barrett,et al. XP13512 [(±)-1-([(α-Isobutanoyloxyethoxy)carbonyl] aminomethyl)-1-cyclohexane Acetic Acid], A Novel Gabapentin Prodrug: I. Design, Synthesis, Enzymatic Conversion to Gabapentin, and Transport by Intestinal Solute Transporters , 2004, Journal of Pharmacology and Experimental Therapeutics.
[13] Tudor I. Oprea,et al. Is There a Difference between Leads and Drugs? A Historical Perspective , 2001, J. Chem. Inf. Comput. Sci..
[14] P. Davidson,et al. Antimicrobials in foods. , 1993 .
[15] Eric F. Johnson,et al. Synthesis and SAR of novel tricyclic quinoxalinone inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1). , 2009, Bioorganic & medicinal chemistry letters.
[16] P. Hajduk,et al. Cheminformatic tools for medicinal chemists. , 2010, Journal of medicinal chemistry.
[17] K. Roemer,et al. The basis for the chemopreventive action of resveratrol. , 2002, Drugs of today.
[18] N. Seeram,et al. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. , 2004, Anticancer research.
[19] N. Seeram,et al. Cyclooxygenase inhibitory and antioxidant compounds from crabapple fruits. , 2003, Journal of agricultural and food chemistry.
[20] P. Kilmartin,et al. Influence of grape-harvesting steps on varietal thiol aromas in Sauvignon blanc wines. , 2011, Journal of agricultural and food chemistry.
[21] D. Newman,et al. Natural products as sources of new drugs over the last 25 years. , 2007, Journal of natural products.
[22] P. Workman,et al. The identification of novel PLC-gamma inhibitors using virtual high throughput screening. , 2009, Bioorganic & medicinal chemistry.
[23] Norman L. Allinger,et al. Conformational analysis. 130. MM2. A hydrocarbon force field utilizing V1 and V2 torsional terms , 1977 .
[24] P. Leeson,et al. A comparison of physiochemical property profiles of development and marketed oral drugs. , 2003, Journal of medicinal chemistry.
[25] Jóhannes Reynisson,et al. Investigation of the incidence of "undesirable" molecular moieties for high-throughput screening compound libraries in marketed drug compounds. , 2009, European journal of medicinal chemistry.
[26] C. Szabó,et al. The Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors , 2002, Pharmacological Reviews.
[27] F. Scheer,et al. Daily Nighttime Melatonin Reduces Blood Pressure in Male Patients With Essential Hypertension , 2004, Hypertension.
[28] M. Nair,et al. Relative inhibition of lipid peroxidation, cyclooxygenase enzymes, and human tumor cell proliferation by natural food colors. , 2005, Journal of agricultural and food chemistry.
[29] Tudor I. Oprea,et al. Current trends in lead discovery: Are we looking for the appropriate properties? , 2004, Molecular Diversity.
[30] D. Trist,et al. The continuing evolution of the drug discovery process in the pharmaceutical industry. , 2001, Farmaco.
[31] R. Torella,et al. Red wine consumption improves insulin resistance but not endothelial function in type 2 diabetic patients. , 2005, Metabolism: clinical and experimental.
[32] F. Speizer,et al. Beverage Use and Risk for Kidney Stones in Women , 1998, Annals of Internal Medicine.
[33] P. Chatonnet,et al. Elebage des vins rouges en fûts de chêne : évolution de certains composés volatils et de leur impact arômatique , 1990 .
[34] T. O'Brien,et al. Fragment-based drug discovery. , 2004, Journal of medicinal chemistry.
[35] Li Xing,et al. Influence of molecular flexibility and polar surface area metrics on oral bioavailability in the rat. , 2004, Journal of medicinal chemistry.
[36] Wendy A. Warr,et al. Fragment-based drug discovery , 2009, J. Comput. Aided Mol. Des..
[37] G. Rishton. Reactive compounds and in vitro false positives in HTS , 1997 .
[38] M. Fontecave,et al. Resveratrol, a remarkable inhibitor of ribonucleotide reductase , 1998, FEBS letters.
[39] Christopher P Austin,et al. Quantitative analyses of aggregation, autofluorescence, and reactivity artifacts in a screen for inhibitors of a thiol protease. , 2010, Journal of medicinal chemistry.
[40] D. Goldberg,et al. Wine and Health: A Paradigm for Alcohol and Antioxidants , 2010 .
[41] P. Kilmartin,et al. Influence of juice pressing conditions on polyphenols, antioxidants, and varietal aroma of Sauvignon blanc microferments. , 2010, Journal of agricultural and food chemistry.
[42] G. Rishton. Nonleadlikeness and leadlikeness in biochemical screening. , 2003, Drug discovery today.
[43] J. Baell,et al. New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. , 2010, Journal of medicinal chemistry.
[44] Jóhannes Reynisson,et al. Benchmarking the reliability of QikProp. Correlation between experimental and predicted values , 2008 .
[45] I. Reynisdottir,et al. The effect of PLC-γ2 inhibitors on the growth of human tumour cells. , 2012, European journal of medicinal chemistry.